DAWN
Price
$12.43
Change
+$0.20 (+1.64%)
Updated
Feb 21 closing price
Capitalization
1.25B
2 days until earnings call
SMMT
Price
$22.12
Change
-$0.94 (-4.08%)
Updated
Feb 21 closing price
Capitalization
16.31B
One day until earnings call
Ad is loading...

DAWN vs SMMT

Header iconDAWN vs SMMT Comparison
Open Charts DAWN vs SMMTBanner chart's image
Day One Biopharmaceuticals
Price$12.43
Change+$0.20 (+1.64%)
Volume$758.3K
Capitalization1.25B
Summit Therapeutics
Price$22.12
Change-$0.94 (-4.08%)
Volume$3.38M
Capitalization16.31B
DAWN vs SMMT Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. SMMT commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Hold and SMMT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (DAWN: $12.43 vs. SMMT: $22.12)
Brand notoriety: DAWN and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 77% vs. SMMT: 144%
Market capitalization -- DAWN: $1.25B vs. SMMT: $16.31B
DAWN [@Biotechnology] is valued at $1.25B. SMMT’s [@Biotechnology] market capitalization is $16.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 4 bullish, 4 bearish.
  • SMMT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а +1.39% price change this week, while SMMT (@Biotechnology) price change was +3.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

DAWN is expected to report earnings on May 07, 2025.

SMMT is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($16.3B) has a higher market cap than DAWN($1.25B). SMMT YTD gains are higher at: 23.956 vs. DAWN (-1.894). SMMT has higher annual earnings (EBITDA): -183.16M vs. DAWN (-210.08M). DAWN has more cash in the bank: 558M vs. SMMT (487M). DAWN has less debt than SMMT: DAWN (2.62M) vs SMMT (32.5M). DAWN has higher revenues than SMMT: DAWN (102M) vs SMMT (0).
DAWNSMMTDAWN / SMMT
Capitalization1.25B16.3B8%
EBITDA-210.08M-183.16M115%
Gain YTD-1.89423.956-8%
P/E RatioN/A26.36-
Revenue102M0-
Total Cash558M487M115%
Total Debt2.62M32.5M8%
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
24
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNSMMT
RSI
ODDS (%)
Bullish Trend 6 days ago
73%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BWXT101.38-3.44
-3.28%
BWX Technologies
LPTH2.44-0.09
-3.56%
LightPath Technologies
PCSA0.53-0.02
-3.65%
Processa Pharmaceuticals
BBAR19.35-0.98
-4.82%
Banco BBVA Argentina SA
GPRK8.77-0.51
-5.50%
Geopark Limited

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+1.64%
VCYT - DAWN
43%
Loosely correlated
-4.56%
ACLX - DAWN
41%
Loosely correlated
-2.83%
DNLI - DAWN
41%
Loosely correlated
-3.98%
SLNO - DAWN
40%
Loosely correlated
-2.72%
KROS - DAWN
40%
Loosely correlated
-0.09%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-4.08%
BCDA - SMMT
70%
Closely correlated
-4.55%
VBIZF - SMMT
42%
Loosely correlated
N/A
XERS - SMMT
34%
Loosely correlated
-5.54%
DAWN - SMMT
32%
Poorly correlated
+1.64%
ERNA - SMMT
31%
Poorly correlated
-7.08%
More